Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults

Vaccine

Volumn 23, Issue 28, 2005, Pages 3657-3667

  Grimprel, Emmanuel ^a   Von Sonnenburg, Frank ^b   Sänger, Roland ^c   Abitbol, Veronique ^d   Wolter, Joanne M ^e   Schuerman, Lode M ^e  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b UNIVERSITY OF MUNICH   (Germany)

^c GLAXOSMITHKLINE   (Germany)

^d GLAXOSMITHKLINE   (France)

^e GSK   (Belgium)

Author keywords

Adolescents; Booster; dTpa IPV

Indexed keywords

BOOSTRIX POLIO; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS POLIO VACCINE; INACTIVATED VIRUS VACCINE; POLIOMYELITIS VACCINE; POLIORIX; REVAXIS; TETANUS ANTIBODY; TETANUS DIPHTHERIA POLIO VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; IMMUNOGENICITY; KINETICS; MAJOR CLINICAL STUDY; MALE; PAIN; POLIOMYELITIS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TETANUS; VACCINATION;

ADOLESCENT; ADULT; AGED; AGING; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; FRANCE; GERMANY; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; PERTUSSIS VACCINE; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; TETANUS; TETANUS TOXOID; VACCINES, COMBINED; WHOOPING COUGH;

EID: 18844422990     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.013     Document Type: Article

References (33)

1. Q. He, M.K. Viljanen, S. Nikkari, R. Lyytikainen, and J. Mertsola Outcomes of Bordetella pertussis infection in different age groups of an immunized population J Infect Dis 170 1994 873 877
2. L.A. Cattaneo, G.W. Reed, D.H. Haase, M.J. Wills, and K.M. Edwards The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years J Infect Dis 173 1996 1256 1259
3. C.H. von Konig, S. Halperin, M. Riffelmann, and N. Guiso Pertussis of adults and infants Lancet 2 2002 744 750
4. D. Guris, P.M. Strebel, B. Bardenheier, M. Brennan, R. Tachdjian, and E. Finch Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults 1990-1996 Clin Infect Dis 28 1999 1230 1237
5. P.F. Thomas, P.B. McIntyre, and B.B. Jalaludin Survey of pertussis morbidity in adults in Western Sydney Med J Aust 173 2000 74 76
6. G. de Serres, R. Shadmani, B. Duval, N. Boulianne, P. Dery, and M. Douville Fradet Morbidity of pertussis in adolescents and adults J Infect Dis 182 2000 174 179
7. C. Vitek, F. Pascual, A. Baughman, and T. Murphy Increase in deaths from pertussis among young infants in the United States in the 1990s Pediatr Infect Dis J 22 2003 628 634
8. A.M.S. Morris, E.J. Elliott, P. McIntyre, J. Massie, G. Ridley, J. McEniery, G. Knight and contributors to the Australian Paediatric Surveillance Unit (APSU) Hospitalised pertussis in infancy J Paediatr Child Health 38 2002 A2
9. S. Stojanov, J. Liese, and B.H. Belohradsky Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection Infection 28 2000 106 110
10. J. Bass, and L. Zacher Do newborn infants have passive immunity to pertussis? Pediatr Infect Dis J 8 1989 352 353
11. C. Smith, and H. Vyas Early infantile pertussis: increasingly prevalent and potentially fatal Eur J Pediatr 159 2000 898 900
12. Centers for Disease Control and Prevention. Pertussis deaths - United States 2000. MMWR July 19, 2002;51;616-8.
13. Centers for Disease Control and Prevention. Pertussis - United States, 1997-2000. MMWR 2002;51:73-6.
14. D. Floret Les décès par infection bactérienne communautaire. Enquête dans les services de réanimation pédiatrique français Arch Pédiatr 8 Suppl. 2001 705 711
15. N.S. Crowcroft, N. Andrews, C. Rooney, M. Brisson, and E. Miller Deaths from pertussis are underestimated in England Arch Dis Child 86 2002 336 338
16. Bonmarin I, Laurent E, Guiso N, Levy Bruhl D, Renacoq. Surveillance de la coqueluche à l'hopital en 2001. BEH 2003;44.
17. E. Grimprel, S. Baron, D. Levy-Bruhl, J.M. Garnier, E. N'jamkepo, and N. Guiso Influence of vaccination coverage on pertussis transmission in France Lancet 354 1999 1699 1700
18. N.N. Minh, Q. He, A. Ramalho, A. Kaufhold, M.K. Viljanen, and H. Arvilommi Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents Pediatrics 104 1999 e70 http://www.pediatrics.org/ cgi/content/full/104/6/e70
19. P. Van Damme, and M. Burgess Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults Vaccine 22 2004 305 308
20. S. Black Epidemiology of pertussis Pediatr Infect Dis J 16 1997 S85 S89
21. M. Campins-Marti, H.K. Cheng, K. Forsyth, N. Guiso, S. Halperin, and L.M. Huang International Consensus Group on Pertussis Immunisation. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration Vaccine 20 2002 641 646
22. World Health Organization, http://www.who.int/vaccines/GlobalSummary/ Immunization/ScheduleSelect.cfm.
23. Bulletin Epidémiologique Hebdomadaire. Calendrier vaccinal 2003. Avis du Conseil supérieur d'hygiène publique de France 2003;06:33-7.
24. Calendario vacunal de la Asociacion Espanola de Pediatria 2001-2002. Anales Espanoles de Pediatria 2001;55:30-8.
25. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiologisches Bull 2003;32:245-60.
26. P. Bégué, and E. Grimprel Future combined vaccines J Infect Dis 174 1996 295 297
27. D.N. Fisman, D. Agrawal, and K. Leder The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis Clin Infect Dis 35 2002 1368 1375
28. Centers for Disease Control and Prevention. Immunization of health-care workers. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR-18):1-42.
29. L. Loutan Vaccination of the immunocompromised patient Biologicals 25 1997 231 236
30. W.R. Dowdle, E. de Gourville, O.M. Kew, M.A. Pallansch, and D.J. Wood Polio eradication: the OPV paradox Rev Med Virol 13 2003 277 291
31. World Health Organization. Update on February 2004 synchronized polio immunization campaigns in West and Central Africa and National Immunization Days in India. WHO Regional Office for Africa and the WHO Regional Office for South-East Asia; 3 March 2004.
32. S.S. Hsu, and G. Groleau Tetanus in the emergency department: a current review J Emerg Med 20 2001 357 365
33. Centers for Disease Control and Prevention (CDC). In: Atkinson, et al., editors. Epidemiology and prevention of vaccine-preventable diseases. 5th ed.; January 1999.